Matches in Ubergraph for { ?s <http://purl.obolibrary.org/obo/NCIT_P302> ?o ?g. }
- NCIT_C128625 NCIT_P302 "acquired thrombotic thrombocytopenic purpura (aTTP)" @default.
- NCIT_C128646 NCIT_P302 "treatment of patients treated with dabigatran (Pradaxa) when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures, or in life-threatening or uncontrolled bleeding" @default.
- NCIT_C1287 NCIT_P302 "Neutropenia" @default.
- NCIT_C128799 NCIT_P302 "adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH ) breast cancer; unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumors have activating human epidermal growth factor receptor 2 HER2 (ERBB2) mutations." @default.
- NCIT_C13008 NCIT_P302 "Adoptive immunotherapy" @default.
- NCIT_C1303 NCIT_P302 "Chemotherapy-related thrombocytopenia" @default.
- NCIT_C1311 NCIT_P302 "Atopic dermatitis; Kidney transplant rejection, prophylaxis; Liver transplant rejection, prophylaxis" @default.
- NCIT_C131178 NCIT_P302 "deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer" @default.
- NCIT_C131178 NCIT_P302 "patients with deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy." @default.
- NCIT_C1317 NCIT_P302 "Depression; Smoking cessation" @default.
- NCIT_C1319 NCIT_P302 "Endometriosis; In-vitro fertilization; Precocious puberty; Premenstrual syndrome; Prostate cancer; Uterine fibroid tumors" @default.
- NCIT_C1321 NCIT_P302 "Allograft rejection" @default.
- NCIT_C132295 NCIT_P302 "adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC)" @default.
- NCIT_C1326 NCIT_P302 "Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Wilms' tumor; neuroblastoma; soft tissue and bone sarcomas; small cell carcinoma of the lung; lymphomas; multiple myeloma; mesotheliomas; germ cell tumors of the ovary or testis." @default.
- NCIT_C1326 NCIT_P302 "Carcinomas of breast, thyroid, gastric, ovarian, bronchogenic, head and neck, prostate, cervical, pancreatic, uterine, hepatic, and transitional cell bladder carcinomas." @default.
- NCIT_C133238 NCIT_P302 "maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer" @default.
- NCIT_C1333 NCIT_P302 "Chemotherapy-induced cardiomyopathy" @default.
- NCIT_C1336 NCIT_P302 "Acute myeloid leukemia; Chronic lymphocytic leukemia; Cutaneous T-cell lymphoma; Hairy cell leukemia; Langerhans cell histiocytosis; Non-Hodgkins lymphoma; Waldenstroms macroglobulinemia" @default.
- NCIT_C1337 NCIT_P302 "Sjogrens syndrome" @default.
- NCIT_C1345 NCIT_P302 "Hypercalcemia of malignancy; Osteolytic bone lesions of multiple myeloma; Osteolytic bone metastases of breast cancer; Pagets disease" @default.
- NCIT_C134987 NCIT_P302 "Adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC); • Adult and pediatric patients ≥12 years of age with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy; • Adult and pediatric patients ≥12 years of age with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate)." @default.
- NCIT_C1353 NCIT_P302 "Chemotherapy- and postoperative-induced nausea and vomiting, treatment and prophylaxis" @default.
- NCIT_C1355 NCIT_P302 "Calcium supplement; Hypocalcemia; Osteoporosis; Rickets; Tetany" @default.
- NCIT_C135627 NCIT_P302 "von Hippel-Lindau (VHL) disease-associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET)" @default.
- NCIT_C136268 NCIT_P302 "multiple myeloma" @default.
- NCIT_C1365 NCIT_P302 "Ifosfamide-induced hemorrhagic cystitis, prophylaxis" @default.
- NCIT_C136821 NCIT_P302 "follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia" @default.
- NCIT_C136891 NCIT_P302 "early stage HER2-overexpressed/amplified breast cancer" @default.
- NCIT_C1374 NCIT_P302 "Breast cancer; Endometrial-thinning; Endometriosis; In vitro fertilization; Prostate cancer" @default.
- NCIT_C137800 NCIT_P302 "ecurrent ovarian, fallopian tube, or primary peritoneal cancer" @default.
- NCIT_C137825 NCIT_P302 "adult patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 (IDH2) mutation" @default.
- NCIT_C1379 NCIT_P302 "Hormone receptor-positive metastatic breast cancer" @default.
- NCIT_C138099 NCIT_P302 "Recurrent or Metastatic Breast Cancer" @default.
- NCIT_C1381 NCIT_P302 "State IVB Cervical cancer; Colorectal cancer; Esophageal cancer; Gastric cancer; Non-small cell lung cancer; Small cell lung cancer" @default.
- NCIT_C1386 NCIT_P302 "Diagnostic imaging" @default.
- NCIT_C138995 NCIT_P302 "treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test." @default.
- NCIT_C1395 NCIT_P302 "Non-small cell lung cancer; metastatic breast cancer; uterine and cervical cancer; desmoid tumors; advanced Kaposi's sarcoma" @default.
- NCIT_C1408 NCIT_P302 "Prevention and treatment of Mycobacterium avium complex (MAC) and tuberculosis in patients with HIV infection" @default.
- NCIT_C1409 NCIT_P302 "Urinary tract infections; prostatitis" @default.
- NCIT_C1411 NCIT_P302 "AIDS-related Kaposi's sarcoma; Bladder cancer; Breast cancer; Cervical cancer; Endometrial adenocarcinoma; Esophageal cancer; Head and Neck cancer; Lung cancer; non-small cell; Lymphoma; Ovarian cancer; Prostate cancer; Testicular cancer" @default.
- NCIT_C141428 NCIT_P302 "chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)" @default.
- NCIT_C1417 NCIT_P302 "Breast Carcinoma; Prostate Carcinoma; Endometriosis" @default.
- NCIT_C1418 NCIT_P302 "Adjuvant usage in bone metastasis of Breast cancer" @default.
- NCIT_C142168 NCIT_P302 "metastatic or recurrent locally advanced Merkel cell carcinoma (MCC)." @default.
- NCIT_C1423 NCIT_P302 "Ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia" @default.
- NCIT_C1431 NCIT_P302 "Condyloma; Superficial Basal Cell Carcinoma; Actinic Keratosis" @default.
- NCIT_C1440 NCIT_P302 "Adjunctive therapy for urea cycle disorders involving deficiencies of carbamoylphosphate synthetase; ornithine transcarbamylase; or argininosuccinic acid synthetase; S-S and S-C sickle cell disease; S-thalassemia hemoglobinopathy" @default.
- NCIT_C1453 NCIT_P302 "Deep vein thrombosis, prophylaxis; Ischemic complications in unstable angina and non-Q wave myocardial infarction, prophylaxis" @default.
- NCIT_C1468 NCIT_P302 "Heart transplantation; Kidney transplantation; Liver transplantation; Lupus nephritis" @default.
- NCIT_C146860 NCIT_P302 "adults with relapsed or refractory multiple myeloma." @default.
- NCIT_C1469 NCIT_P302 "Radiodetection of ovarian cancer" @default.
- NCIT_C1471 NCIT_P302 "Chronic hepatitis B; HIV infection" @default.
- NCIT_C1474 NCIT_P302 "Aplastic neutropenia; Bone marrow transplantation; Cancer patients receiving myelosuppressive chemotherapy; Congenital neutropenia; Idiopathic or cyclic neutropenia; Peripheral blood progenitor cell mobilization" @default.
- NCIT_C1476 NCIT_P302 "Cutaneous T-cell lymphoma" @default.
- NCIT_C148145 NCIT_P302 "adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy." @default.
- NCIT_C148498 NCIT_P302 "the treatment of adult patients with relapsed or refractory multiple myeloma" @default.
- NCIT_C1485 NCIT_P302 "AIDs, pediatric; HIV infection, pediatric" @default.
- NCIT_C1492 NCIT_P302 "Melanoma; Neutropenia-chemotherapy induced" @default.
- NCIT_C1494 NCIT_P302 "Colorectal carcinoma and medullary thyroid carcinoma detection" @default.
- NCIT_C1501 NCIT_P302 "Adjunctive therapy for the prevention and treatment of hyperammonemia in the chronic management of patients with urea cycle enzymopathy" @default.
- NCIT_C150559 NCIT_P302 "N-acetylglutamate synthase (NAGS) Deficiency Hyperammonemia; thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure" @default.
- NCIT_C1518 NCIT_P302 "Breast cancer; Cardiovascular Disease prophylaxis; Osteoporosis" @default.
- NCIT_C152089 NCIT_P302 "adults and pediatric patients 12 years of age and older with sickle cell disease" @default.
- NCIT_C1526 NCIT_P302 "Breast cancer; Esophageal cancer; Gastric cancer; Head/Neck cancers; Locally Advanced or Metastatic Non small-cell lung cancer; Ovarian cancer; Metastatic Prostate cancer" @default.
- NCIT_C152666 NCIT_P302 "adult patients with relapsed or refractory advanced renal cell carcinoma (RCC)" @default.
- NCIT_C1527 NCIT_P302 "Hormone receptor-positive early breast cancer; Delayed puberty; Endometrial cancer; Ovulatory induction" @default.
- NCIT_C152795 NCIT_P302 "Adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based regimen;; Adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy." @default.
- NCIT_C1528 NCIT_P302 "Osteoporosis, treatment and prevention; Pagets disease" @default.
- NCIT_C153084 NCIT_P302 "Clostridium difficile Infection" @default.
- NCIT_C1533 NCIT_P302 "Malignant pleural mesothelioma; Non-small cell lung cancer" @default.
- NCIT_C153373 NCIT_P302 "pain associated with endometriosis in women" @default.
- NCIT_C1534 NCIT_P302 "PET radiopharmaceutical" @default.
- NCIT_C154272 NCIT_P302 "first-line treatment for patients with metastatic non-small cell lung cancer whose tumors express PD-L1(≥1%), as determined by an FDA-approved test, with no epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genomic tumor aberrations." @default.
- NCIT_C154272 NCIT_P302 "untreated advanced renal cell carcinoma; microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)" @default.
- NCIT_C154287 NCIT_P302 "adult patients with KRAS G12C mutated locally advanced or metastatic non-small cell lung cancer (NSCLC)" @default.
- NCIT_C154325 NCIT_P302 "melanoma with BRAF V600E or V600K mutations, and involvement of lymph node(s), following complete resection; anaplastic thyroid cancer with BRAF V600E mutation" @default.
- NCIT_C154326 NCIT_P302 "unresectable or metastatic melanoma with a BRAF V600E or V600K mutation" @default.
- NCIT_C1555 NCIT_P302 "Refractory metastatic carcinoma of the ovary; AIDS-related Kaposi's sarcoma; breast cancer; relapsed/refractory multiple myeloma (with bortezomib)." @default.
- NCIT_C156401 NCIT_P302 "adult patients with newly diagnosed or relapsed/refractory multiple myeloma" @default.
- NCIT_C156894 NCIT_P302 "acute myeloid leukemia (AML)" @default.
- NCIT_C156895 NCIT_P302 "solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation" @default.
- NCIT_C1569 NCIT_P302 "Kidney transplant rejection, prevention" @default.
- NCIT_C1570 NCIT_P302 "childhood neuroblastoma" @default.
- NCIT_C1574 NCIT_P302 "Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi sarcoma" @default.
- NCIT_C157493 NCIT_P302 "for adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC)." @default.
- NCIT_C1577 NCIT_P302 "Hepatocellular carcinoma" @default.
- NCIT_C158060 NCIT_P302 "HER2 overexpressing breast cancer" @default.
- NCIT_C1581 NCIT_P302 "Radiation-induced oral mucositis" @default.
- NCIT_C158136 NCIT_P302 "To control high blood sugar in people with type 2 diabetes, with a proper diet and exercise program" @default.
- NCIT_C1583 NCIT_P302 "Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia" @default.
- NCIT_C158617 NCIT_P302 "relapsed or refractory mantle cell lymphoma (MCL)" @default.
- NCIT_C1587 NCIT_P302 "In combination therapies for acute myelogenous leukemia and pediatric acute lymphocytic leukemia." @default.
- NCIT_C159541 NCIT_P302 "prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients (ages newborn and older) with hemophilia A (congenital factor VIII deficiency) with or without factor VIII (FVIII) inhibitors" @default.
- NCIT_C1599 NCIT_P302 "Metastatic prostate cancer" @default.
- NCIT_C1607 NCIT_P302 "Hormone Receptor-Positive Early Breast cancer" @default.
- NCIT_C162995 NCIT_P302 "intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF)." @default.
- NCIT_C1635 NCIT_P302 "Oral or topical treatment of cutaneous manifestations of cutaneous T-cell lymphoma (CTCL)." @default.
- NCIT_C1639 NCIT_P302 "Hyperthyroidism" @default.
- NCIT_C1643 NCIT_P302 "Pneumococcal Prophylaxis" @default.
- NCIT_C1646 NCIT_P302 "Peripheral blood progenitor cell mobilizer" @default.